MichaelSIpMD

PubMed

• Reply.
  Neal L Oden, Paul C VanVeldhuisen, Ingrid U Scott, Michael S Ip, Barbara A Blodi> ;Ophthalmology. 2024 Apr 1
• Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.
  Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L Bilano, Franklin Igwe, Marco A Zarbin, Mathew W MacCumber, Michael S Ip, Charles C Wykoff> ;Ophthalmology and Therapy. 2024 May 1
• Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.
  Shechtman, D., Karpecki, P., Rafieetary, M., Regillo, C., Nijm, L., Kaiser, P., Ryan, E., Ip, M., Yeu, E., Kim, T., Donnenfeld, E.> ;Clinical Ophthalmology. 2024 Jan 1
• Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion.
  Michael S Ip, Ingrid U Scott, Paul C VanVeldhuisen, Neal L Oden, Barbara A Blodi> ;American Journal of Ophthalmology. 2024 Apr 1
• 3 citations
  Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.
  Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum, Sunir Joshi, David Warrow, Veeral S Sheth, Jana Stefanickova, Yong Soo Kim, Fanyin He, Ga Eun Cho, ...> ;JAMA Ophthalmology. 2023 Dec 1
• Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 27.
  Ahmad A Aref, Ingrid U Scott, Neal L Oden, Michael S Ip, Paul C VanVeldhuisen, Barbara A Blodi> ;JAMA Ophthalmology. 2023 Dec 1
• Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment.
  Peter K Kaiser, Paul M Karpecki, Carl D Regillo, Caroline Baumal, Edwin H Ryan, Michael S Ip, Yasha Modi, Elizabeth Yeu, Lisa Nijm, Marjan Farid, Ronald Luke Rebenitsc...> ;BMJ Open Ophthalmology. 2023 Oct 1
• OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2.
  Adrian Au, Michael Ip, Barbara A Blodi, Ingrid U Scott, Neal L Oden, Paul C Van Veldhuisen, David Sarraf> ;American Journal of Ophthalmology. 2023 Dec 1
• 1 citations
  Macular Sensitivity Endpoints in Geographic Atrophy: Exploratory Analysis of Chroma and Spectri Clinical Trials.
  Dolly S Chang, Natalia F Callaway, Verena Steffen, Karl Csaky, Robyn H Guymer, David G Birch, Praveen J Patel, Michael Ip, Simon S Gao, Jayla Briggs, Lee Honigberg, Ph...> ;Ophthalmology Science. 2023 Jun 12
• High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21.
  Nitish Mehta, Vikram Modi, Rachel Vardi, Kevin Liu, Rishi P Singh, David Sarraf, Neal L Oden, Paul C VanVeldhuisen, Ingrid U Scott, Michael S Ip, Barbara A Blodi, Yash...> ;Translational Vision Science & Technology. 2023 Jun 1
• 1 citations
  SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.
  Ingrid U Scott, Neal L Oden, Paul C VanVeldhuisen, Michael S Ip, Barbara A Blodi> ;Ophthalmology. 2023 Oct 1
• 1 citations
  Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial.
  Steven M Kymes, Neal L Oden, Paul C VanVeldhuisen, Ingrid U Scott, Michael S Ip, Barbara A Blodi, Jacquie King> ;JAMA Ophthalmology. 2023 Jun 1
• 2 citations
  One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry.
  Mathew W MacCumber, Charles C Wykoff, Helene Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita Freitas, Michael S I...> ;Ophthalmology. 2023 Sep 1
• 2 citations
  Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.
  Mathew W MacCumber, Charles C Wykoff, Helene Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita Freitas, Michael S I...> ;Ophthalmology. 2023 Aug 1
• Visit Adherence and Visual Acuity in Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).
  Brian L VanderBeek, Yinxi Yu, Neal Oden, Paul VanVeldhuisen, Barbara Blodi, Michael Ip, Ingrid U Scott> ;Ophthalmic Epidemiology. 2024 Feb 1
• OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
  Swetha Bindu Velaga, Muneeswar Gupta Nittala, Ahmed Roshdy Alagorie, Jyotsna Marram, Zhihong Jewel Hu, Ziyuan Wang, Thomas A Ciulla, Barry Kapik, Srinivas R Sadda, Mic...> ;Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024 Apr 1
• 17 citations
  Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17).
  Rupert W Strauss, Alexander Ho, Anamika Jha, Kaoru Fujinami, Michel Michaelides, Artur V Cideciyan, Isabelle Audo, David G Birch, Srinivas Sadda, Michael Ip, Sheila We...> ;American Journal of Ophthalmology. 2023 Jun 1
• SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes.
  Ingrid U Scott, Neal L Oden, Paul C VanVeldhuisen, Michael S Ip, Barbara A Blodi> ;American Journal of Ophthalmology. 2023 Apr 1
• IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER Studies.
  David Eichenbaum, David M Brown, Michael Ip, Arshad M Khanani, Marta S Figueroa, Ian L McAllister, Augustinus Laude, Guruprasad B, Shuhan Tang, Benjamin Gmeiner, Andre...> ;Retina. 2023 Apr 1
• 1 citations
  In Vivo Longitudinal Measurement of Cone Photoreceptor Density in Intermediate Age-Related Macular Degeneration.
  Xiaolin Wang, SriniVas R Sadda, Michael S Ip, David Sarraf, Yuhua Zhang> ;American Journal of Ophthalmology. 2023 Apr 1
• 2 citations
  RETINAL VASCULAR BED AREA IN EYES WITH RETINAL VEIN OCCLUSION ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY: WAVE Study.
  Wenying Fan, Alan Fleming, Jano Van Hemert, Charles C Wykoff, David M Brown, Gavin Robertson, Kang Wang, Khalil Ghasemi Falavarjani, Srinivas R Sadda, Michael Ip> ;Retina. 2022 Oct 1
• 5 citations
  Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion.
  Ingrid U Scott, Paul C VanVeldhuisen, Neal L Oden, Michael S Ip, Barbara A Blodi> ;American Journal of Ophthalmology. 2022 Aug 1
• 4 citations
  Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy.
  Charles C Wykoff, Muneeswar G Nittala, Cecilia Villanueva Boone, Hannah J Yu, Wenying Fan, Swetha Bindu Velaga, Justis P Ehlers, Michael S Ip, SriniVas R Sadda> ;Ophthalmology. Retina. 2022 Jul 1
• 2 citations
  Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.
  Thomas A Ciulla, Barry Kapik, Allen Hu, Alon Harris, Michael S Ip, Barbara Blodi> ;Ophthalmology. Retina. 2022 Dec 1
• 1 citations
  Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared ...
  Ingrid U Scott, Neal L Oden, Paul C VanVeldhuisen, Michael S Ip, Barbara A Blodi> ;JAMA Ophthalmology. 2022 May 1
• Join now to see all